Literature DB >> 21440047

Early onset deficits on the delayed alternation task in the Hdh(Q92) knock-in mouse model of Huntington's disease.

R C Trueman1, L Jones, S B Dunnett, S P Brooks.   

Abstract

A number of genetic mouse models of Huntington's disease have been created, in order to examine the pathogenesis of Huntington's disease and to test potential therapeutics. In the present study we demonstrate that the full-length knock-in homozygote Hdh(Q92) mice exhibit impairments at 5 months of age on the delayed alternation task, conducted in 9-hole operant chambers. This test is sensitive to cortico-striatal dysfunction and demonstrates again that although Hdh(Q92) mice do not display an overt motor phenotype, they do exhibit clear impairments that can be related to deficits seen in HD patients. This indicates that if appropriately sensitive tasks are used, the more subtle and specific Hdh(Q92) knock-in model could be of use for the examination of pathogenic mechanisms in Huntington's disease and to test potential therapeutics.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440047     DOI: 10.1016/j.brainresbull.2011.03.012

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory.

Authors:  Erik Karl Håkan Clemensson; Laura Emily Clemensson; Olaf Riess; Huu Phuc Nguyen
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

2.  Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice.

Authors:  Vadim Alexandrov; Dani Brunner; Liliana B Menalled; Andrea Kudwa; Judy Watson-Johnson; Matthew Mazzella; Ian Russell; Melinda C Ruiz; Justin Torello; Emily Sabath; Ana Sanchez; Miguel Gomez; Igor Filipov; Kimberly Cox; Mei Kwan; Afshin Ghavami; Sylvie Ramboz; Brenda Lager; Vanessa C Wheeler; Jeff Aaronson; Jim Rosinski; James F Gusella; Marcy E MacDonald; David Howland; Seung Kwak
Journal:  Nat Biotechnol       Date:  2016-07-04       Impact factor: 54.908

3.  Executive functions in premanifest Huntington's disease.

Authors:  S Christine You; Michael D Geschwind; Sharon J Sha; Alexandra Apple; Gabriella Satris; Kristie A Wood; Erica T Johnson; Jonathan Gooblar; Jeanne S Feuerstein; Steven Finkbeiner; Gail A Kang; Bruce L Miller; Christopher P Hess; Joel H Kramer; Katherine L Possin
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

4.  A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.

Authors:  Emma Yhnell; Stephen B Dunnett; Simon P Brooks
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

Review 5.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

6.  Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's disease.

Authors:  Ivan Rattray; Edward J Smith; William R Crum; Thomas A Walker; Richard Gale; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

7.  A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Authors:  Sabine M Hölter; Mary Stromberg; Marina Kovalenko; Lillian Garrett; Lisa Glasl; Edith Lopez; Jolene Guide; Alexander Götz; Wolfgang Hans; Lore Becker; Birgit Rathkolb; Jan Rozman; Anja Schrewed; Martin Klingenspor; Thomas Klopstock; Holger Schulz; Eckhard Wolf; Wolfgang Wursta; Tammy Gillis; Hiroko Wakimoto; Jonathan Seidman; Marcy E MacDonald; Susan Cotman; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.